Ophelia amasses $50m Series B

Ophelia, a digital provider of medication-assisted treatment for opioid use disorder, has raised $50 million in Series B funding.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this